188 related articles for article (PubMed ID: 7835575)
1. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group.
Brignola C; Cottone M; Pera A; Ardizzone S; Scribano ML; De Franchis R; D'Arienzo A; D'Albasio G; Pennestri D
Gastroenterology; 1995 Feb; 108(2):345-9. PubMed ID: 7835575
[TBL] [Abstract][Full Text] [Related]
2. Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
Florent C; Cortot A; Quandale P; Sahmound T; Modigliani R; Sarfaty E; Valleur P; Dupas JL; Daurat M; Faucheron JL; Lerebours E; Michot F; Belaiche J; Jacquet N; Soulé JC; Rothman N; Gendre JP; Malafosse M
Eur J Gastroenterol Hepatol; 1996 Mar; 8(3):229-33. PubMed ID: 8724022
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease.
McLeod RS; Wolff BG; Steinhart AH; Carryer PW; O'Rourke K; Andrews DF; Blair JE; Cangemi JR; Cohen Z; Cullen JB
Gastroenterology; 1995 Aug; 109(2):404-13. PubMed ID: 7615189
[TBL] [Abstract][Full Text] [Related]
4. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.
Hanauer SB; Korelitz BI; Rutgeerts P; Peppercorn MA; Thisted RA; Cohen RD; Present DH
Gastroenterology; 2004 Sep; 127(3):723-9. PubMed ID: 15362027
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.
Lochs H; Mayer M; Fleig WE; Mortensen PB; Bauer P; Genser D; Petritsch W; Raithel M; Hoffmann R; Gross V; Plauth M; Staun M; Nesje LB
Gastroenterology; 2000 Feb; 118(2):264-73. PubMed ID: 10648454
[TBL] [Abstract][Full Text] [Related]
6. Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial.
Caprilli R; Cottone M; Tonelli F; Sturniolo G; Castiglione F; Annese V; Papi C; Viscido A; Cammà C; Corrao G; Latella G
Aliment Pharmacol Ther; 2003 Feb; 17(4):517-23. PubMed ID: 12622760
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of Crohn's disease in the neoterminal ileum after ileal resection: is prevention therapy possible?
Rutgeerts P
Neth J Med; 1994 Aug; 45(2):60-4. PubMed ID: 7936007
[TBL] [Abstract][Full Text] [Related]
8. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group.
Sutherland LR; Martin F; Bailey RJ; Fedorak RN; Poleski M; Dallaire C; Rossman R; Saibil F; Lariviere L
Gastroenterology; 1997 Apr; 112(4):1069-77. PubMed ID: 9097988
[TBL] [Abstract][Full Text] [Related]
9. Early post-operative endoscopic recurrence in Crohn's disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort.
Orlando A; Mocciaro F; Renna S; Scimeca D; Rispo A; Lia Scribano M; Testa A; Aratari A; Bossa F; Tambasco R; Angelucci E; Onali S; Cappello M; Fries W; D'Incà R; Martinato M; Castiglione F; Papi C; Annese V; Gionchetti P; Rizzello F; Vernia P; Biancone L; Kohn A; Cottone M
J Crohns Colitis; 2014 Oct; 8(10):1217-21. PubMed ID: 24630485
[TBL] [Abstract][Full Text] [Related]
10. Remaining small bowel endoscopic lesions at surgery have no influence on early anastomotic recurrences in Crohn's disease.
Klein O; Colombel JF; Lescut D; Gambiez L; Desreumaux P; Quandalle P; Cortot A
Am J Gastroenterol; 1995 Nov; 90(11):1949-52. PubMed ID: 7484997
[TBL] [Abstract][Full Text] [Related]
11. Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
Modigliani R; Colombel JF; Dupas JL; Dapoigny M; Costil V; Veyrac M; Duclos B; Soulé JC; Gendre JP; Galmiche JP; Danne O; Cadiot G; Lamouliatte H; Belaïche J; Mary JY
Gastroenterology; 1996 Mar; 110(3):688-93. PubMed ID: 8608877
[TBL] [Abstract][Full Text] [Related]
12. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.
Reinisch W; Angelberger S; Petritsch W; Shonova O; Lukas M; Bar-Meir S; Teml A; Schaeffeler E; Schwab M; Dilger K; Greinwald R; Mueller R; Stange EF; Herrlinger KR;
Gut; 2010 Jun; 59(6):752-9. PubMed ID: 20551460
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC).
Caprilli R; Corrao G; Taddei G; Tonelli F; Torchio P; Viscido A
Dis Colon Rectum; 1996 Mar; 39(3):335-41. PubMed ID: 8603558
[TBL] [Abstract][Full Text] [Related]
14. Postoperative recurrence of Crohn's disease: pathogenesis and prevention.
D'Haens GR; Rutgeerts PJ
Acta Gastroenterol Belg; 1994; 57(5-6):311-3. PubMed ID: 7709700
[TBL] [Abstract][Full Text] [Related]
15. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
Savarino E; Bodini G; Dulbecco P; Assandri L; Bruzzone L; Mazza F; Frigo AC; Fazio V; Marabotto E; Savarino V
Am J Gastroenterol; 2013 Nov; 108(11):1731-42. PubMed ID: 24019080
[TBL] [Abstract][Full Text] [Related]
16. [Postoperative recurrence in Crohn's disease].
Caprilli R; Taddei G; Viscido A
Chir Ital; 1995; 47(5):25-32. PubMed ID: 9162601
[TBL] [Abstract][Full Text] [Related]
17. Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group.
Singleton JW; Hanauer SB; Gitnick GL; Peppercorn MA; Robinson MG; Wruble LD; Krawitt EL
Gastroenterology; 1993 May; 104(5):1293-301. PubMed ID: 8482443
[TBL] [Abstract][Full Text] [Related]
18. [5-Aminosalicylic acid in the prevention of recurrences of Crohn's disease].
Del Corso L; Moruzzo D; Romanelli AM; Norpoth M; Pentimone F; Bresci G
Dtsch Med Wochenschr; 1995 Dec; 120(50):1723-7. PubMed ID: 8542807
[TBL] [Abstract][Full Text] [Related]
19. A controlled double blind multicenter study of the effectiveness of 5-aminosalicylic acid in patients with Crohn's disease in remission.
Arber N; Odes HS; Fireman Z; Lavie A; Broide E; Bujanover Y; Becker S; Pomerantz I; Moshkowitz M; Patz J
J Clin Gastroenterol; 1995 Apr; 20(3):203-6. PubMed ID: 7797827
[TBL] [Abstract][Full Text] [Related]
20. Is it possible to prevent recurrent Crohn's disease with medical or surgical interventions?
Mcleod RS
Neth J Med; 1996 Feb; 48(2):68-70. PubMed ID: 8819803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
